Plus Therapeutics
PSTV
PSTV
30 hedge funds and large institutions have $35.4M invested in Plus Therapeutics in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
65% less call options, than puts
Call options by funds: $178K | Put options by funds: $511K
Holders
30
Holding in Top 10
–
Calls
$178K
Puts
$511K
Top Buyers
| 1 | +$873K | |
| 2 | +$423K | |
| 3 | +$291K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$288K |
| 5 |
GCM
Goldman Capital Management
New York
|
+$261K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$847K | |
| 3 | -$834K | |
| 4 |
D.E. Shaw & Co
New York
|
-$295K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$289K |